|
|
|
|
|
|
|
S&P Biotech SPDR (XBI)
|
|
99.08 0.02 (0.02%)
|
06-22 16:00
|
|
Open:
|
99.37
|
Pre. Close:
|
99.06
|
|
High:
|
99.54
|
Low:
|
98.1
|
|
Volume:
|
3,781,118
|
Market Cap:
|
9136M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
99.652 - 100.048
|
100.048 - 100.389
|
|
Low:
|
96.998 - 97.49
|
97.49 - 97.914
|
|
Close:
|
98.235 - 99.033
|
99.033 - 99.721
|
|
|
|
Technical analysis (as of: 2018-06-22 4:35:55 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 118.61 One year: 138.54
|
|
Support:
|
Support1: 95.17 Support2: 91.23
|
|
Resistance:
|
Resistance1:
101.55 Resistance2: 118.61
|
|
Pivot:
|
97.64 
|
|
Moving Averages:
|
MA(5): 99.12 MA(20): 96.78
MA(100): 91.65 MA(250): 86.46
|
|
MACD:
|
MACD(12,26):
1.90  Signal(12,26,9): 1.82
|
|
%K %D:
|
%K(14,3): 75.86 %D(3): 85.80
|
|
RSI:
|
RSI(14): 63.51
|
|
52-Week:
|
High: 101.55
Low: 74.25 Change(%): 23.7
|
|
Average Vol(K):
|
3-Month: 464031
10-Days 509208
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.XBI has closed below upper band by 22.9%. Bollinger Bands are 39.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-06-22T14:39:45-04:00
Alzheimer's And Infectious Disease: For Real
2018-06-22T12:07:17-04:00
Can frothy biotech IPO pace keep up
2018-06-22T06:59:07-04:00
Rounds Report: Solid Biosciences Made Big Waves While The FDA Approved Eversense
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
